Clinical Trial: ES002023-1001

Trial Status: Open
Disease Type: Solid Tumors All
Trial ID ES002023-1001
Sponsor ID Elpiscience Biopharma

An Open-Label, Mulitcenter, First-in-Human, Dose Escalation, Phase 1 Study of ES002023 in Patients with Locally Advanced or Metastatic Solid Tumors


Fairfax Office

Learn More About This Trial

Other Relevant Trials
Trial ID TSC-007

A Phase 2 multi-center open-label basket trial of ABI-009 (nab-sirolimus) for adult and adolescent patients with solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes

Trial ID 516-014
Sponsor ID Mirati

A Multicenter, Open-Label, Extension Study of the Safety and Tolerability of Sitravatinib Alone or in Combination with Other Anticancer Therapies in Patients with Advanced or Metastatic Solid Malignancies